BioSpace News Archive

allStEquities.com is offering reports on AKER, ATRS, BAX, and BDX.

Sanofi: First-quarter 2018 Business EPS up 1.4% at CER

Sinovac Biotech Ltd. announced that on April 26, 2018, it entered into Amendment No. 2 to the Amalgamation Agreement (the “Amendment”) to further amend the Amalgamation Agreement.

Invitae Corporation announced that it is launching a new program with Biogen.

Blink Fitness is excited to announce the grand opening of its 69th location, in Newark.

Fidelis Care recently earned the distinction of being the top-ranked health plan in New York State in the Department of Health’s 2017 Quality Incentive results for Medicaid Managed Care plans.

Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, today announced that data from its preclinical research will be highlighted in presentations and posters at the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting, April 29 – May 3, in Honolulu, HI

ACADIA Pharmaceuticals Inc. issued a statement.

Sinovac Biotech Ltd. announced that it will delay the filing of its annual report on Form 20-F for the year 2017.

The Janssen Pharmaceutical Companies of Johnson & Johnson announced the results of a real-world study showing that adults with type 2 diabetes initiated on INVOKANA®.